Barclays’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-113,490
| Closed | -$2.04M | – | 4575 |
|
|
2017
Q4 | $2.04M | Buy |
113,490
+93,313
| +462% | +$1.68M | ﹤0.01% | 1252 |
|
|
2017
Q3 | $239K | Buy |
20,177
+10,597
| +111% | +$126K | ﹤0.01% | 2306 |
|
|
2017
Q2 | $101K | Sell |
9,580
-12,102
| -56% | -$128K | ﹤0.01% | 2766 |
|
|
2017
Q1 | $238K | Sell |
21,682
-55,503
| -72% | -$609K | ﹤0.01% | 2393 |
|
|
2016
Q4 | $1.05M | Buy |
77,185
+76,727
| +16,753% | +$1.04M | ﹤0.01% | 1469 |
|
|
2016
Q3 | $6K | Sell |
458
-142
| -24% | -$1.86K | ﹤0.01% | 3393 |
|
|
2016
Q2 | $7K | Sell |
600
-6,441
| -91% | -$75.1K | ﹤0.01% | 3079 |
|
|
2016
Q1 | $70K | Buy |
7,041
+611
| +10% | +$6.07K | ﹤0.01% | 2437 |
|
|
2015
Q4 | $109K | Sell |
6,430
-8,008
| -55% | -$136K | ﹤0.01% | 2272 |
|
|
2015
Q3 | $274K | Buy |
14,438
+9,294
| +181% | +$176K | ﹤0.01% | 2000 |
|
|
2015
Q2 | $83K | Buy |
5,144
+4,071
| +379% | +$65.7K | ﹤0.01% | 2439 |
|
|
2015
Q1 | $16K | Sell |
1,073
-3,167
| -75% | -$47.2K | ﹤0.01% | 3208 |
|
|
2014
Q4 | $60K | Sell |
4,240
-1,473
| -26% | -$20.8K | ﹤0.01% | 2924 |
|
|
2014
Q3 | $34K | Sell |
5,713
-5,364
| -48% | -$31.9K | ﹤0.01% | 3185 |
|
|
2014
Q2 | $67K | Buy |
11,077
+697
| +7% | +$4.22K | ﹤0.01% | 2925 |
|
|
2014
Q1 | $72K | Buy |
10,380
+5,948
| +134% | +$41.3K | ﹤0.01% | 2956 |
|
|
2013
Q4 | $39K | Sell |
4,432
-768
| -15% | -$6.76K | ﹤0.01% | 3497 |
|
|
2013
Q3 | $31K | Buy |
5,200
+3,949
| +316% | +$23.5K | ﹤0.01% | 3368 |
|
|
2013
Q2 | $9K | Buy |
+1,251
| New | +$9K | ﹤0.01% | 3936 |
|